ALCON-COUVREUR, n.v. s.a. ,   Belgium

Antiglaucoma combined (carbonic anhydrase inhibitor + beta-adrenoblocker)

Eye drops.

Antiglaucoma preparation, inhibitor of carbonic anhydrase

Eye drops 1%.

local anesthetic

Eye drops, 0,5%.

Anti-glaucoma - beta-blocker

Eye drops, 0,5%.

Anti-glaucoma - beta-blocker

Eye drops, 0,25%.

Antimicrobial agent - fluoroquinolone
Eye drops 0.5%.
antiglaucoma agents combined (prostaglandin F2-alpha analogue synthetic + beta-blocker)
Eye drops.
Cataract treatment

Eye drops 0.015%.

glucocorticosteroid for topical application
Eye drops, 0,1%.
glucocorticosteroid for topical application
Eye ointment, 0,1%.
glucocorticosteroid for topical use + antibiotics (aminoglycoside and cyclic polypeptide)

Eye drops.

M-holinoblokator

Eye drops 0.5%; 1%.

nonsteroidal anti-inflammatory drug.

Eye drops 0.1%.

5 ml per bottle-dropper "Droptainer™" from low density polyethylene. By

1 A bottle with instructions for use in a pack of cardboard.

antiallergic agent - H1-histamine receptor blocker

Eye drops, 0,1%.

keratoprotective agent

Eye drops.

glucocorticosteroid for topical use + antibiotic-aminoglycoside

Eye drops.

glucocorticosteroid for topical use + antibiotic-aminoglycoside
Ointment eye.
Antibiotic. Aminoglycoside
Eye ointment 0.3%.
Antiglaucoma means - prostaglandin F2-alpha analogue is synthetic.
Eye drops 40 μg / ml.